Open Heart

SEPTEMBER 18, 2024

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk for life-threatening arrhythmias. These devices offer a non-invasive and temporary solution, providing continuous monitoring and the potential for prompt defibrillation when needed.

Defibrillator 52

Defibrillator Sudden Cardiac Death Arrhythmia Outpatient 52

HeartRhythm

JANUARY 8, 2025

Brugada syndrome (BrS) is a genetic heart disease that predisposes individuals to ventricular arrhythmias and sudden cardiac death. Although implantable cardioverter-defibrillators (ICDs) and quinidine are primary treatments, recurrent BrS-triggered ventricular arrhythmias can persist.

Sudden Cardiac Death 73

Sudden Cardiac Death Ablation Defibrillator Arrhythmia 73

DAIC

SEPTEMBER 5, 2024

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. chief medical officer of the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic.

Defibrillator 52

Defibrillator Sudden Cardiac Death Quality of Life Tachycardia 52

MIBHS

MARCH 31, 2025

Unlike a heart attack, cardiac arrest is an electrical malfunction that causes the heart to stop beating suddenly. Without immediate intervention, sudden cardiac death can occur within minutes. Use an automated external defibrillator (AED) if available. Call for emergency medical assistance immediately.

Cardiac Arrest 52

Cardiac Arrest Heart attacks Heart Attack Chest Pain 52

HeartRhythm

MARCH 20, 2025

Sudden cardiac death is an important cause of mortality in patients with kidney failure undergoing renal replacement therapy, either hemodialysis or peritoneal dialysis. The risk factors associated with sudden cardiac death in these patients only partly overlap with those in the general population.

Sudden Cardiac Death 45

Sudden Cardiac Death Defibrillator Risk Factors 45

Journal of Cardiovascular Electrophysiology

APRIL 2, 2025

ABSTRACT The first viable alternative to surgical implantation of an epicardial defibrillator system for secondary prevention of sudden cardiac death (SCD) was a single chamber transvenous implantable cardioverter defibrillator (ICD).

Defibrillator 40

Defibrillator Sudden Cardiac Death Technology 40

Ken Grauer, MD

JUNE 27, 2024

C ASE C onclusion: As noted above — today's patient developed cardiac arrest shortly after arrival in the ED. Despite prolonged resuscitation with multiple defibrillation attempts — the patient could not be saved. = Bidirectional VT: Challenges and Solutions ( Almarzuqi et al — Vasc Health Risk Mgmt 18:3997-406, 2022 ).

Blog 160

Blog Cardiac Arrest Sudden Cardiac Death Tachycardia 160

Open Heart

MARCH 8, 2024

The wearable cardioverter defibrillator (WCD) is becoming a more and more widely used instrument for the prevention of sudden cardiac death of patients either with a secondary prevention implantable cardioverter defibrillator indication or with a transient high risk of sudden cardiac death.

Sudden Cardiac Death 52

Sudden Cardiac Death Defibrillator Atrial Fibrillation Arrhythmia 52

HeartRhythm

FEBRUARY 4, 2025

The main function of the implantable cardioverter-defibrillator (ICD) is to protect against sudden cardiac death (SCD) due to ventricular tachyarrhythmia (VTA).

Heart Failure 45

Heart Failure Defibrillator Sudden Cardiac Death 45

Open Heart

NOVEMBER 21, 2024

Possible arrhythmic recurrences and the risk of sudden cardiac death (SCD) in this setting are reasons for concern, and limited data have been published to guide clinical management of these patients.

Sudden Cardiac Death 52

Sudden Cardiac Death Defibrillator Tachycardia Risk Factors 52

Medical Xpress - Cardiology

JULY 29, 2024

Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of sudden cardiac death (SCD). With an estimated incidence as high as 22% among these patients, current clinical guidelines recommend using implantable cardioverter defibrillators (ICDs) to help mitigate the risk of SCD.

Sudden Cardiac Death 40

Sudden Cardiac Death Heart Failure Defibrillator 40

Circulation

NOVEMBER 27, 2024

BACKGROUND:Declining cardiovascular mortality rates have been well-documented, yet temporal trends of sudden cardiac death (SCD) in young individuals remain unclear. to 28%, mainly because of increased bystander cardiopulmonary resuscitation and defibrillation rates. Circulation, Ahead of Print.

Sudden Cardiac Death 49

Sudden Cardiac Death Defibrillator Cardiac Arrest Certification 49

HeartRhythm

APRIL 30, 2024

Implantable cardiac defibrillators (ICDs) are a fundamental therapy used in the prevention of sudden cardiac death (SCD). Contemporary trials have been incorporated into national guidelines to support their use. However, the elderly are usually excluded or not well represented.

Defibrillator 40

Defibrillator Sudden Cardiac Death Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD). Since approval in late 2012, the subcutaneous implantable cardioverter-defibrillator (SICD) has been used as an alternative to the traditional transvenous ICD (TV-ICD) for SCD prevention in HCM.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiomyopathy 40

HeartRhythm

APRIL 30, 2024

The subcutaneous implantable cardioverter defibrillator (S-ICD) has emerged as an alternative to transvenous ICD for the prevention of sudden cardiac death in patients without pacing indications.

Defibrillator 40

Defibrillator Sudden Cardiac Death Outcomes 40

HeartRhythm

APRIL 30, 2024

The use of implantable cardioverter-defibrillators (ICD) for primary prevention (PP) of sudden cardiac death among select patients with heart failure (HF) is recommended by the HRS, AHA and ACC. However, whether ICDs may be underutilized within a safety-net system has not been studied.

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death 40

HeartRhythm

APRIL 30, 2024

Implantable cardioverter defibrillators (ICD) are used for primary and secondary prevention of sudden cardiac death. In this case, we highlight a unique complication of increased defibrillator shock impedance in a patient with breast implants followed by normalization after breast implant removal.

Defibrillator 40

Defibrillator Sudden Cardiac Death 40

HeartRhythm

APRIL 30, 2024

Wearable cardioverter-defibrillator (WCD) is an alternative option for the prevention of sudden cardiac death in patients at high risk for malignant ventricular arrhythmias.

Defibrillator 40

Defibrillator Sudden Cardiac Death Arrhythmia 40

HeartRhythm

JULY 14, 2024

The subcutaneous implantable cardioverter-defibrillator (S-ICD) has emerged as an alternative to transvenous systems for preventing sudden cardiac death. However, concerns have been raised regarding its efficacy and safety in obese individuals.

Defibrillator 40

Defibrillator Sudden Cardiac Death Obesity 40

HeartRhythm

APRIL 30, 2024

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD). Since approval in late 2012, the subcutaneous implantable cardioverter-defibrillator (SICD) has been used as an alternative to the traditional transvenous ICD (TV-ICD) for SCD prevention in HCM.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiomyopathy 40

Circulation

MARCH 31, 2024

Circulation, Volume 149, Issue 14 , Page 1059-1061, April 2, 2024.

Sudden Cardiac Death 45

Sudden Cardiac Death Defibrillator Circulation 45

HeartRhythm

NOVEMBER 27, 2024

Despite an elevated risk of sudden cardiac death among dialysis patients, implantable cardioverter defibrillators (ICDs) have not been shown to improve mortality and are associated with high complication rates.

Defibrillator 40

Defibrillator Sudden Cardiac Death Outcomes 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 22, 2024

ABSTRACT Introduction Substernal extravascular defibrillators (EV ICDs) have been shown to be effective and safe for patients at risk of sudden cardiac death, however, there is little evidence around the safety of extracting chronic devices.

Defibrillator 40

Defibrillator Sudden Cardiac Death 40

American College of Cardiology

OCTOBER 18, 2024

Does use of left ventricular ejection fraction (LVEF) and/or other variables identify patients who benefit from defibrillator implantation to prevent sudden death after acute myocardial infarction (MI)?

Sudden Cardiac Death 48

Sudden Cardiac Death Myocardial Infarction Defibrillator Article 48

HeartRhythm

APRIL 30, 2024

Subcutaneous implantable cardioverter-defibrillators (S-ICDs) alleviate many issues associated with a transvenous system, while having similar efficacy to transvenous ICDs at preventing sudden cardiac death. However, S-ICDs have higher rates of shocks due to a lack of anti-tachycardia pacing (ATP).

Defibrillator 40

Defibrillator Tachycardia Sudden Cardiac Death 40

Open Heart

AUGUST 25, 2023

Background Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%.

Defibrillator 52

Defibrillator Sudden Cardiac Death Myocardial Infarction Echocardiogram 52

HeartRhythm

JULY 15, 2024

Despite the abundance of evidence supporting the use of implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death (SCD), racial and gender inequities in ICD implantation persist.1,2

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death 40

HeartRhythm

APRIL 30, 2024

ß-blockers and flecainide have been used for treatment of VT as were implantable cardioverter defibrillators (ICD) for prevention of sudden cardiac death (SCD).

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator 40

All About Cardiovascular System and Disorders

MARCH 17, 2024

Here is the transcript of the video: Implantable defibrillator is an important life saving device. Then, why is it mentioned that, implanting a defibrillator soon after an acute myocardial infarction, in those with left ventricular dysfunction and prone for ventricular arrhythmias and sudden cardiac death, is not useful?

Myocardial Infarction 52

Myocardial Infarction Defibrillator Sudden Cardiac Death Arrhythmia 52

HeartRhythm

APRIL 30, 2024

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias.

Atrial Fibrillation 40

Atrial Fibrillation Defibrillator Sudden Cardiac Death Tachycardia 40

HeartRhythm

MAY 29, 2024

The implantable cardioverter defibrillator (ICD) improves survival in patients at risk of sudden cardiac death (1).

Defibrillator 40

Defibrillator Sudden Cardiac Death Quality of Life Exercise 40

Heart BMJ

JANUARY 10, 2024

Sudden cardiac death is one of the main causes of mortality in patients with known or occult cardiac disease and is potentially preventable by early resuscitation.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiac Arrest Arrhythmia 40

HeartRhythm

SEPTEMBER 4, 2023

Over the course of several decades, the transvenous implantable cardioverter-defibrillator (TV-ICD) has grown to become a safe and effective treatment for the prevention of sudden cardiac death. During this time, there have been numerous iterative refinements to the system and implant technique.

Defibrillator 40

Defibrillator Sudden Cardiac Death Technology 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 3, 2025

However, limited data exist on the global trends of implantable cardioverter defibrillator (ICD) utilization and its impact on mortality/morbidity burden reduction.METHODS:Electronic databases were systematically searched up to March 2024 for studies reporting on ICD utilization rates in hypertrophic cardiomyopathy. Mean age was 46.2

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator Cardiomyopathy Outcomes 40

DAIC

FEBRUARY 12, 2024

5,6 “We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring,” said Ryan Walters, BIOTRONIK US President. Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001. 2023;12:e029126. O'Connor M, et al.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

Circulation

NOVEMBER 11, 2024

Background:Epicardial patch defibrillators (EPDs) were commonly implanted in the 1990s for secondary prevention of sudden cardiac death. This case highlights such a scenario.Case:A 75-year-old female with a history of cardiac arrest 30 years ago presented with shortness of breath and left leg swelling.

Defibrillator 40

Defibrillator Cardiac Arrest Sudden Cardiac Death Coronary Angiogram 40

HeartRhythm

MAY 7, 2024

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

Sudden Cardiac Death 45

Sudden Cardiac Death Tachycardia Cardiomyopathy Ablation 45